Incyte Corp (NASDAQ:INCY)

78.59
Delayed Data
As of Oct 21
 +0.83 / +1.07%
Today’s Change
57.00
Today|||52-Week Range
89.30
+23.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$16.7B

Company Description

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Contact Information

Incyte Corp.
1801 Augustine Cut-Off
Wilmington Delaware 19803
P:(302) 498-6700
Investor Relations:
(302) 498-5914

Employees

Shareholders

Mutual fund holders50.94%
Other institutional45.15%
Individual stakeholders18.18%

Top Executives

There are no executives to display.